A new month is upon us, so what better time to look through our portfolios and see if there are any new additions that could be made to take it to the next level.
If you're a fan of growth shares then I think the three listed below could be worth considering in February:
Bravura Solutions Ltd (ASX: BVS)
Bravura Solutions is the fintech company behind the hugely popular Sonata wealth management platform. I've been very impressed at the way the platform has been growing over the last few years. In fact, its growth has been so strong that it has now become the company's biggest contributor to earnings. Due to its massive addressable market and the quality of the product, I expect the platform to put Bravura Solutions in a position to deliver above-average earnings growth over the coming years.
ResMed Inc (ASX: RMD)
Last week this sleep treatment medical device provider's shares crashed 12% lower after its solid second quarter result fell short of the market's lofty expectations. Unfortunately, unless its U.S. listed shares rebound strongly on Wall Street tonight from their 19% decline on Friday night, its ASX listed shares are likely to fall further when the market reopens on Tuesday. While this is disappointing, I think it is an opportunity to buy the shares of one of Australia's highest quality companies at a fair price.
Webjet Limited (ASX: WEB)
A third and final growth share to consider buying in February is this leading online travel agent. Thanks to the popularity of its numerous B2B and B2C brands, I believe Webjet is well-positioned to achieve its aim of continuing to grow bookings at many times the industry average over the medium term. After a solid start to the year management expects EBITDA growth of 26% in FY 2019, excluding the benefits of the Destinations of the World acquisition.
